If you found a bug or would like to request a feature, please file an issue. If, based on the discussion on an issue, you would like to offer a code change, please make a pull request.

Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the AACR ...

Institut de Génétique Et de Biologie Moléculaire Et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258/CNRS UMR 7104, Illkirch 67404, France ...

Abstract: Accurate interpretation of human emotions and micro-expressions is vital for advancing human-computer interaction, enhancing security systems, and supporting psychological research.

Enfortumab vedotin and pembrolizumab combination achieved a 39% objective response rate in PD-L1 positive recurrent/metastatic HNSCC patients. Disease control rate was 75.6%, with responses observed ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...

Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda prove to be fruitful, as demonstrated through its Keynote-B96 trial in ovarian ...

Background: Programmed cell death-ligand 1 (PD-L1) immunohistochemical expression currently is the only approved useful biomarker associated with the PD-1/PD-L1 immune checkpoint blockade (ICB) ...

1 Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea 2 Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The ...